From the Department of Public Health, Texas Tech University Health Sciences Center, Lubbock, TX.
Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN.
Menopause. 2022 Oct 1;29(10):1150-1160. doi: 10.1097/GME.0000000000002031. Epub 2022 Aug 20.
The activity, localization, and turnover of proteins within cells and plasma may contribute to physiologic changes during menopause and may influence disease occurrence. We examined cross-sectional differences and long-term changes in plasma proteins between premenopausal and naturally postmenopausal women.
We used data from 4,508 (19% Black) women enrolled in the Atherosclerosis Risk in Communities study. SOMAscan multiplexed aptamer technology was used to measure 4,697 plasma proteins. Linear regression models were used to compare differences in proteins at baseline (1993-1995) and 18-year change in proteins from baseline to 2011-2013.
At baseline, 472 women reported being premenopausal and 4,036 women reported being postmenopausal, with average ages of 52.3 and 61.4 years, respectively. A greater proportion of postmenopausal women had diabetes (15 vs 9%), used hypertension (38 vs 27%) and lipid-lowering medications (10 vs 3%), and had elevated total cholesterol and waist girth. In multivariable adjusted models, 38 proteins differed significantly between premenopausal and postmenopausal women at baseline, with 29 of the proteins also showing significantly different changes between groups over the 18-year follow-up as the premenopausal women also reached menopause. These proteins were associated with various molecular/cellular functions (cellular development, growth, proliferation and maintenance), physiological system development (skeletal and muscular system development, and cardiovascular system development and function), and diseases/disorders (hematological and metabolic diseases and developmental disorders).
We observed significantly different changes between premenopausal and postmenopausal women in several plasma proteins that reflect many biological processes. These processes may help to understand disease development during the postmenopausal period.
细胞内和血浆中蛋白质的活性、定位和周转率可能导致绝经期间的生理变化,并可能影响疾病的发生。我们检查了绝经前和自然绝经后妇女之间血浆蛋白的横断面差异和长期变化。
我们使用了参加动脉粥样硬化风险社区研究的 4508 名(19%为黑人)女性的数据。SOMAscan 多重适体技术用于测量 4697 种血浆蛋白。线性回归模型用于比较基线(1993-1995 年)和从基线到 2011-2013 年的蛋白质 18 年变化之间蛋白质的差异。
基线时有 472 名女性报告处于绝经前,4036 名女性报告处于绝经后,平均年龄分别为 52.3 岁和 61.4 岁。绝经后女性中糖尿病(15%比 9%)、高血压(38%比 27%)和降脂药物(10%比 3%)的使用比例更高,总胆固醇和腰围也更高。在多变量调整模型中,38 种蛋白质在绝经前和绝经后女性之间存在显著差异,其中 29 种蛋白质在 18 年的随访中也显示出两组之间的显著变化,因为绝经前女性也进入了绝经期。这些蛋白质与各种分子/细胞功能(细胞发育、生长、增殖和维持)、生理系统发育(骨骼和肌肉系统发育以及心血管系统发育和功能)以及疾病/障碍(血液和代谢疾病以及发育障碍)相关。
我们观察到绝经前和绝经后女性之间的几种血浆蛋白存在显著差异,这些差异反映了许多生物学过程。这些过程可能有助于理解绝经后期间疾病的发展。